Ultrasound-guided vacuum procedure study after early pregnancy loss
Part of Genetic & congenital, Immune system & allergy clinical trials.
This trial studies a medicine-product made from conception tissue (from an ultrasound-guided manual vacuum aspiration procedure) for people with an early miscarriage or termination. It may help researchers understand whether this approach is safe and potentially beneficial for recovery, but eligibility depends on specific medical and procedural factors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 18 or older.
- You are having an early miscarriage or termination (first trimester).
- Your bleeding and vital signs are stable, and you can tolerate an exam with a speculum (tool used to gently open the vagina).
- Your pregnancy loss fits one of these ultrasound situations: no heartbeat at early size, or incomplete loss with a small pregnancy/uterine measurement (POG under 5 cm).
- You can safely undergo the manual vacuum aspiration procedure (no issues like tight cervix, certain uterine problems, heavy fibroids, bleeding disorders, active infection/sepsis, or inability to tolerate pelvic exams).
- You do not have a major current psychological/psychiatric problem and you do not refuse participation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies an ultrasound-guided procedure that removes pregnancy tissue using gentle suction. It may help people with an early miscarriage who are stable and meet specific anatomy and safety requirements.
This study tests whether adding a type of acupuncture (Acu-TENS) to standard care can reduce pain during a procedure to remove pregnancy tissue after a first-trimester miscarriage. If you are eligible, you may receive either acupuncture with a mild electrical current or a placebo device during the procedure.
This study tests a non-invasive way to monitor pregnancies that may be at risk for miscarriage. It might help detect problems early so you and your doctor can act.
This study tests a cross-linked hyaluronan gel placed in the uterus to help prevent painful or disruptive scar tissue (adhesions) after a procedure using ultrasound guidance. If you are eligible, the trial may help reduce the chance of future fertility and menstrual problems caused by scar tissue.
This study compares two surgical procedures for removing pregnancy tissue after an early miscarriage: hysteroscopic resection and manual vacuum aspiration. It helps you understand which method might work best.
This trial compares two ways to treat a first-trimester miscarriage that needs surgery: one is done in a clinic using a handheld suction device, the other is done in an operating room using electric suction. The study looks at costs and how well each method works.
Hear when a new Genetic Anticipation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.